Unimodal treatment for nonsmall cell lung cancer: dawn of a renaissance?

Symposium
Chairs: S. Elia (Rome, Italy), F. Gamarra (Munich, Germany), H. Saka (Nagoya, Japan)
Aims: The audience will learn the modern indications of unimodal treatment for lung cancer, taking into account stage, histology, performance status, age and comorbidities.
Targeted substances and no more?
A.P. Meert (Brussels, Belgium)
Slide presentationMultimedia files
Slide presentationMultimedia files